Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine tolerability with acute thrombolysis for ischemic stroke
2020-002531-30Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of acetylcysteine in ischemic stroke, sponsored by CHU Caen Normandie. Primary endpoint: Symptomatic intracranial hemorrhage rate. Started Jun 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2020-002531-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002531-30.